High incidence of inflammatory bowel disease in The Netherlands

1998 ◽  
Vol 41 (1) ◽  
pp. 33-40 ◽  
Author(s):  
M. G. V. M. Russel ◽  
E. Dorant ◽  
A. Volovics ◽  
R.-J. Brummer ◽  
P. Pop ◽  
...  
Keyword(s):  
Inflammatory Bowel Disease ◽  
The Netherlands ◽  
Bowel Disease ◽  
High Incidence ◽  
Inflammatory Bowel

scholarly journals Importance of Screening Colonoscopy for Colorectal Cancer among Inflammatory Bowel Disease Patients in Qatar

2020 ◽  
Vol 5 (4) ◽  
Keyword(s):  
Colorectal Cancer ◽  
Inflammatory Bowel Disease ◽  
Bowel Disease ◽  
Colorectal Adenocarcinoma ◽  
Screening Colonoscopy ◽  
International Guidelines ◽  
Incidence And Mortality ◽  
High Incidence ◽  
High Incidence Rate ◽  
Inflammatory Bowel

Since 1920, inflammatory bowel disease (IBD) has been linked to increased incidence and mortality from colorectal adenocarcinoma (CRC). Several studies have found that screening colonoscopy reduced CRC mortality and improved survival in IBD patients. However, there are little or no data about the prevalence of CRC/Dysplasia in Qatar detected by screening colonoscopy and weather the Qatar gastroenterologists adhere to the international guidelines. Thus, the focus of the present study was to examine the rate of CRC and dysplasia in IBD patients who underwent a screening colonoscopy. The sample consisted of 153 patients who were diagnosed and treated for IBD. The results of the study showed high incidence rate of CRC/Dysplasia among IBD patients and it was also found that the gastroenterologists in Qatar did not strictly adhere to the international guidelines in relation to the time of first screening colonoscopy of IBD patients.

scholarly journals P328 Faecal microbiota transplantation as treatment for recurrent Clostridiodes difficile infection in patients with inflammatory bowel disease: Experiences of the Netherlands donor faeces bank

2020 ◽  
Vol 14 (Supplement_1) ◽  
pp. S317-S318
Author(s):  
E Van Lingen ◽  
A E van der Meulen-de Jong ◽  
K E W Vendrik ◽  
E J Kuijper ◽  
E M Terveer ◽  
...  
Keyword(s):  
Ulcerative Colitis ◽  
Inflammatory Bowel Disease ◽  
The Netherlands ◽  
Bowel Disease ◽  
Working Group ◽  
Indeterminate Colitis ◽  
Cure Rate ◽  
Faecal Microbiota ◽  
Faecal Microbiota Transplantation ◽  
Inflammatory Bowel

Abstract Background In recent years Faecal Microbiota Transplantation (FMT) is effectively implemented as an approved treatment approach of refractory Clostridiodes difficile infection (rCDI). In patients with inflammatory bowel disease (IBD) the prevalence of co-infection with CDI is higher than in the general population due to the use of immunosuppressive medication and dysbiosis of the bacteria in the colon. Just a small percentage of IBD patients do have an active CDI infection, not to be confused with carriership. Here we report the treatment course and efficacy of FMT provided by the Netherlands Donor Faeces Bank (NDFB) for IBD patients with rCDI. Methods The NDFB was founded to facilitate FMT by providing ready to use donor faeces suspensions for treatment of patients with rCDI in hospitals throughout The Netherlands. A request for FMT is evaluated by the working group (specialists in the fields of Medical Microbiology, Gastroenterology, and Infectious Diseases) to assess the indication of FMT and to formulate a treatment advice for each individual patient taking the comorbidity into account. Prior to FMT, all patients were pre-treated with vancomycin 250 mg for at least 4 days and bowel lavage. In patients with ulcerative colitis as comorbidity, prednisone was added when there was an IBD flare simultaneous. The results of FMT were monitored by prospective collection of outcome data by the NDFB. Results Since the start of NDFB in March 2016 until August 2019, 186 FMT requests to treat 176 (r)CDI patients were reviewed within the NDFB working group including 26 patients with rCDI and IBD. In total, 129 patients (of which 14 suffered from IBD) were treated with 143 FMTs for CDI with a cure rate of 89.9% after a single FMT (116/129). FMT was deemed not suitable in 12 of 26 patients with IBD because patients had C. Difficile carriership instead of an active CDI infection. Fourteen IBD patients were treated with FMT (9 ulcerative colitis, 2 Crohn’s disease and 2 indeterminate colitis). 3/14 patients suffered from rCDI with an active episode of IBD. Of the 14 IBD patients treated with FMT, only one patient developed a relapse of a CDI infection within 2-months (total cure rate 92%). This cure rate does not differ from CDI patients without IBD. Conclusion In IBD patients with rCDI, FMT is equally effective compared with other patients with rCDI. In case of concurrent activity of IBD, pre-treatment with prednisolone in combination with vancomycin appears to be effective.

scholarly journals Inflammatory Bowel Disease in South Limburg (the Netherlands) 1991–2002: Incidence, diagnostic delay, and seasonal variations in onset of symptoms

2009 ◽  
Vol 3 (2) ◽  
pp. 115-124 ◽  
Author(s):  
Mariëlle J.L. Romberg-Camps ◽  
Martine A.M. Hesselink-van de Kruijs ◽  
Leo J. Schouten ◽  
Pieter C. Dagnelie ◽  
Charles B. Limonard ◽  
...  
Keyword(s):  
Inflammatory Bowel Disease ◽  
The Netherlands ◽  
Bowel Disease ◽  
Seasonal Variations ◽  
Diagnostic Delay ◽  
Inflammatory Bowel
Sign in / Sign up

Export Citation Format

Share Document